Fujifilm has announced that its Diosynth Biotechnologies in the UK will make the Novavax COVID-19 vaccine.
Work at its plant in Billingham, Stockton-on-Tees, will employ more than 300 and start this month, with workers making more than 60 million doses. The plant - at which 800 work - makes wideformat printers, inks and piezo printheads, as well as offset plates and chemistry.
Novavax, which is based in Maryland, USA, is to supply 51 million doses of the vaccine to Australia and 10.7 million for New Zealand, Wideformat Online magazine has reported.
How you can help us at GXpress.net
These are difficult times, and in order for us to continue to provide the
GXpress news service FREE, we ask you to please register here to join our newsletter list
(your email will not be passed to any third party, and you can unsubscribe later).
Please register even if you currently get the newsletter, to ensure continuity and stop these messages
|While we discontinued print editions at the end of 2018, you can still download back editions as PDF|
|Visit these dedicated online departments|
|INDUSTRY | DIGITAL | PRINT | JOIN GXpress (It's free)||© Copyright MPC Media, Pileport Pty Ltd. 2021|
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: